← Back to Clinical Trials
Recruiting NCT06909409
D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
Trial Parameters
Condition Idiopathic Pulmonary Fibrosis (IPF)
Sponsor University of Aarhus
Study Type OBSERVATIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-10-11
Completion 2026-10-11
Brief Summary
The goal of this observational study is to gain deeper insights into human macrophages and vitamin D, and their interplay, within Idiopathic Pulmonary Fibrosis (IPF). The overall questions, it aims to answer, are the following: Do IPF patients suffer from systemic and local (pulmonary) insufficient levels of vitamin D? Do IPF patients suffer from pro-fibrotic and pro-inflammatory pulmonary macrophages?
Eligibility Criteria
Inclusion Criteria: * A clinical diagnosis of IPF, non-IPF ILD or lung cancer * A signed informed consent Exclusion Criteria: * Do not speak Danish/Do not understand Danish
Related Trials
NCT06909409
D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
View Trial →
NCT07482917
Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial
View Trial →
NCT07174102
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Compu
View Trial →